BSX
Price
$105.26
Change
+$0.76 (+0.73%)
Updated
May 30 closing price
Capitalization
100.1B
52 days until earnings call
MDT
Price
$82.98
Change
+$0.57 (+0.69%)
Updated
May 30 closing price
Capitalization
115.55B
79 days until earnings call
Interact to see
Advertisement

BSX vs MDT

Header iconBSX vs MDT Comparison
Open Charts BSX vs MDTBanner chart's image
Boston Scientific
Price$105.26
Change+$0.76 (+0.73%)
Volume$10.52M
Capitalization100.1B
Medtronic
Price$82.98
Change+$0.57 (+0.69%)
Volume$11.03M
Capitalization115.55B
BSX vs MDT Comparison Chart
Loading...
BSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BSX vs. MDT commentary
Jun 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSX is a Buy and MDT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 01, 2025
Stock price -- (BSX: $105.26 vs. MDT: $82.98)
Brand notoriety: BSX and MDT are both notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BSX: 125% vs. MDT: 144%
Market capitalization -- BSX: $100.1B vs. MDT: $115.55B
BSX [@Medical Specialties] is valued at $100.1B. MDT’s [@Medical Specialties] market capitalization is $115.55B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BSX’s FA Score shows that 3 FA rating(s) are green whileMDT’s FA Score has 1 green FA rating(s).

  • BSX’s FA Score: 3 green, 2 red.
  • MDT’s FA Score: 1 green, 4 red.
According to our system of comparison, BSX is a better buy in the long-term than MDT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BSX’s TA Score shows that 5 TA indicator(s) are bullish while MDT’s TA Score has 4 bullish TA indicator(s).

  • BSX’s TA Score: 5 bullish, 5 bearish.
  • MDT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BSX is a better buy in the short-term than MDT.

Price Growth

BSX (@Medical Specialties) experienced а +0.73% price change this week, while MDT (@Medical Specialties) price change was +2.85% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.06%. For the same industry, the average monthly price growth was +2.33%, and the average quarterly price growth was -2.29%.

Reported Earning Dates

BSX is expected to report earnings on Jul 23, 2025.

MDT is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Medical Specialties (+1.06% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MDT($116B) has a higher market cap than BSX($100B). BSX has higher P/E ratio than MDT: BSX (63.64) vs MDT (27.63). BSX YTD gains are higher at: 17.846 vs. MDT (4.705). MDT has higher annual earnings (EBITDA): 8.91B vs. BSX (3.45B). MDT has more cash in the bank: 8.32B vs. BSX (865M). BSX has less debt than MDT: BSX (9.49B) vs MDT (25.2B). MDT has higher revenues than BSX: MDT (32.3B) vs BSX (14.2B).
BSXMDTBSX / MDT
Capitalization100B116B86%
EBITDA3.45B8.91B39%
Gain YTD17.8464.705379%
P/E Ratio63.6427.63230%
Revenue14.2B32.3B44%
Total Cash865M8.32B10%
Total Debt9.49B25.2B38%
FUNDAMENTALS RATINGS
BSX vs MDT: Fundamental Ratings
BSX
MDT
OUTLOOK RATING
1..100
9214
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
4
Undervalued
PROFIT vs RISK RATING
1..100
4100
SMR RATING
1..100
7075
PRICE GROWTH RATING
1..100
3358
P/E GROWTH RATING
1..100
2776
SEASONALITY SCORE
1..100
n/a12

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MDT's Valuation (4) in the Medical Specialties industry is significantly better than the same rating for BSX (86). This means that MDT’s stock grew significantly faster than BSX’s over the last 12 months.

BSX's Profit vs Risk Rating (4) in the Medical Specialties industry is significantly better than the same rating for MDT (100). This means that BSX’s stock grew significantly faster than MDT’s over the last 12 months.

BSX's SMR Rating (70) in the Medical Specialties industry is in the same range as MDT (75). This means that BSX’s stock grew similarly to MDT’s over the last 12 months.

BSX's Price Growth Rating (33) in the Medical Specialties industry is in the same range as MDT (58). This means that BSX’s stock grew similarly to MDT’s over the last 12 months.

BSX's P/E Growth Rating (27) in the Medical Specialties industry is somewhat better than the same rating for MDT (76). This means that BSX’s stock grew somewhat faster than MDT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BSXMDT
RSI
ODDS (%)
Bearish Trend 2 days ago
31%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
47%
Bullish Trend 2 days ago
52%
Momentum
ODDS (%)
Bullish Trend 2 days ago
60%
Bearish Trend 2 days ago
47%
MACD
ODDS (%)
Bearish Trend 2 days ago
50%
Bearish Trend 2 days ago
60%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
50%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
59%
Bearish Trend 2 days ago
51%
Advances
ODDS (%)
Bullish Trend 13 days ago
63%
Bullish Trend 2 days ago
49%
Declines
ODDS (%)
Bearish Trend 3 days ago
46%
Bearish Trend 9 days ago
54%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
58%
Bullish Trend 2 days ago
49%
Aroon
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
39%
View a ticker or compare two or three
Interact to see
Advertisement
BSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ENLV0.94N/A
-0.17%
Enlivex Therapeutics Ltd
GRC36.50-0.17
-0.46%
Gorman-Rupp Company (The)
AB39.95-0.21
-0.52%
AllianceBernstein Holding LP
ICLR130.28-0.79
-0.60%
ICON plc
FET14.74-0.22
-1.47%
Forum Energy Technologies

BSX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BSX has been closely correlated with ISRG. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if BSX jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSX
1D Price
Change %
BSX100%
+0.73%
ISRG - BSX
73%
Closely correlated
-0.61%
SYK - BSX
69%
Closely correlated
+0.08%
MMSI - BSX
62%
Loosely correlated
+0.22%
NTRA - BSX
51%
Loosely correlated
-0.20%
ALC - BSX
48%
Loosely correlated
-0.47%
More

MDT and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDT has been loosely correlated with SYK. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if MDT jumps, then SYK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDT
1D Price
Change %
MDT100%
+0.69%
SYK - MDT
55%
Loosely correlated
+0.08%
STE - MDT
48%
Loosely correlated
+0.09%
ABT - MDT
47%
Loosely correlated
+0.55%
BSX - MDT
46%
Loosely correlated
+0.73%
BAX - MDT
46%
Loosely correlated
-0.10%
More